Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well cinacalcet hydrochloride works in treating men with
recurrent prostate cancer. Cinacalcet hydrochloride may be effective in lowering
prostate-specific antigen (PSA) levels in patients with recurrent prostate cancer that has
not responded to previous treatment
Phase:
Phase 2
Details
Lead Sponsor:
Comprehensive Cancer Center of Wake Forest University Wake Forest University Health Sciences